Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 21 Sept 2026 for Oruka Therapeutics, Inc., €311k. Read the official filing
Filing timeline
BuySalePaul T. Quinlan
Insider track record
Disclosed buys
0
Disclosed sells
12
Signal history
Paul T. Quinlan: trading record in brief
This profile gathers the share dealings of Paul T. Quinlan across 2 companies, led by Oruka Therapeutics, Inc. and CymaBay Therapeutics, Inc. In total, 28 filings cover trades dated from 15 May 2023 to 21 September 2026.
Sales make up the whole of the open-market record (12 sales, €5.8M). The rest of the record consists of 2 share grants and 13 option exercises. 2026 to date brings no purchases and 12 sales.
On 21 September 2026 came the latest disclosure, an open-market sale for €311k in Oruka Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul T. Quinlan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
3,832 shares@ US$93.31730.0063% mcap4.9% of flowCommon StockSEC:0000907654-26-000100:2
10,000 shares@ US$7.800.0014% mcap1.1% of flowCommon StockSEC:0000907654-26-000100:0
2,900 shares@ US$92.36890.0047% mcap3.6% of flowCommon StockSEC:0000907654-26-000100:1
2,667 shares@ US$95.31150.0044% mcap3.5% of flowCommon StockSEC:0000907654-26-000100:4
601 shares@ US$94.44260.0010% mcap0.8% of flowCommon StockSEC:0000907654-26-000100:3
1,039 shares@ US$95.710.0017% mcap1.3% of flowCommon StockSEC:0000907654-26-000095:0
10,000 shares@ US$7.800.0014% mcap1.1% of flowCommon StockSEC:0000907654-26-000077:0
42,000 shares@ US$12.500.0091% mcap7.1% of flowCommon StockSEC:0000907654-26-000077:1
3,630 shares@ US$106.05040.0067% mcap5.2% of flowCommon StockSEC:0000907654-26-000077:2
10,434 shares@ US$107.14020.019% mcap15.1% of flowCommon StockSEC:0000907654-26-000077:3
14,696 shares@ US$107.97350.028% mcap21.5% of flowCommon StockSEC:0000907654-26-000077:4
10,200 shares@ US$109.11310.019% mcap15.1% of flowCommon StockSEC:0000907654-26-000077:5
9,193 shares@ US$110.00390.018% mcap13.7% of flowCommon StockSEC:0000907654-26-000077:6
3,847 shares@ US$111.13780.0074% mcap5.8% of flowCommon StockSEC:0000907654-26-000077:7
733 shares@ US$41.300.4% of flowCommon StockSEC:0000907654-26-000029:0
32,500 shares0Common StockSEC:0000907654-26-000014:0
41,824 sharesCommon StockSEC:0000950170-24-035453:0
41,824 shares@ US$7.8971.3% of flowCommon StockSEC:0001062993-24-006510:0
28,438 shares0Common StockSEC:0001062993-24-001429:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-24-000923:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-022636:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-021137:0
5,000 shares@ US$2.943.3% of flowCommon StockSEC:0001062993-23-019547:0
5,000 shares@ US$2.943.3% of flowCommon StockSEC:0001062993-23-018278:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-016606:0
25 of 28 declarations
